Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....
Depot Medroxyprogesterone Injection Market: By Type, By End User, By Application, and Geography
Depot Medroxyprogesterone Injection Market size was valued at US$ 934.0 million in 2023 and is poised to grow at a significant CAGR of 4.0% from 2024 - 2030. The injectable progestin-only contraceptive depot medroxyprogesterone acetate (DMPA, often known as Depo-Provera) provides very effective, discreet, three-month reversible contraception. DMPA removes the necessity for daily user activity, action close to sexual intercourse, and partner collaboration. By legalizing the use of injectable contraceptives, developing countries are focusing on lowering infant and mother mortality rates. For example, Haryana was the first state in India to implement the use of injectable contraceptives. The project would start in nine districts across the state, with the injectable available for free at all district hospitals, primary health centers, and community health centers. The United Kingdom authorities authorized Sayana Press in 2015, a three-month progestin-only injectable contraception.
The governmental and private partners declared at the London Summit that they would deliver around 12 million doses of Sayana Press to the world's poorest countries by 2020. Injections have traditionally been a popular method of contraception in Sub-Saharan Africa, and the introduction of the Sayana Press injection and Uniject device is expected to increase demand. The all-in-one prefilled injectable device increases access through non-clinical channels while improving safety. The unmet need for contraception remains high. An estimated 225 million women in developing countries would like to delay or prevent pregnancy but are not using any method of contraception. Common reasons include difficulty traveling to health facilities, social barriers, and lack of knowledge about available contraceptive methods. Developing countries are home to more significant population density; it is imperative that governments and local organizations play a pivotal role in creating awareness about family planning, thereby reducing the number of childbirths and population. This could potentially create a market opportunity for the players who offer contraceptive injections at affordable prices. Moreover, the growing demographic dividend in these regions and an increase in fertility rate will positively impact the contraceptive markets in general. It may present a lucrative opportunity for market players with greater market penetration and access to injectable formulations.
Study Period
2024-2030Base Year
2023CAGR
4%Largest Market
North AmericaFastest Growing Market
Asia pacific
The growing demand for birth control measures and government attempts to raise awareness about various contraceptive methods are driving the market for Depot Medroxyprogesterone Injection. Various forecasting projects are underway to assess better the demand for Depot medroxyprogesterone acetate (DMPA) as a birth control method. For instance, The Concept Foundation hired the William Davidson Institute (WDI) in January 2015 to research DMPA demand in low- and middle-income nations. Manufacturers are now attempting to produce a subcutaneous low-dose injectable of medroxyprogesterone acetate to reduce some weight gain and metabolic side effects. On the other hand, DMPA has long been connected to various health problems, including osteoporosis, breast cancer, and a delayed return of fertility. In addition, long-term use of DPMA may result in a loss of bone mineral density; these factors restrain the depot medroxyprogesterone injection market.
Report Benchmarks |
Details |
Report Study Period |
2024-2030 |
Market Size in 2023 |
US$ 934.0 million |
Market CAGR |
4% |
By Type |
|
By Application |
|
By End User |
|
Download Free Sample Report
The depot medroxyprogesterone injection market size was valued at US$ 934.0 million in 2023
The depot medroxyprogesterone injection market key players are: Pfizer Inc. Fangtong Pharma. Co. Ltd Gador S.A. Sigma-Aldrich Co. LLC. Teva Pharmaceutical Industries Ltd. Greenstone LLC Serum Internation Ltd. West-Coast Pharmaceutical Arrow Pharma Group, Zuche Pharmaceuticals Pvt. Ltd.
The depot medroxyprogesterone injection market has been classified into North America, Asia Pacific, Europe, Latin America, Middle East and Africa, and the rest of MEA.
1. Executive Summary |
2. Global Depot Medroxyprogesterone Injection Market Introduction |
2.1.Global Depot Medroxyprogesterone Injection Market - Taxonomy |
2.2.Global Depot Medroxyprogesterone Injection Market - Definitions |
2.2.1.Type |
2.2.2.Application |
2.2.3.End Users |
2.2.4.Region |
3. Global Depot Medroxyprogesterone Injection Market Dynamics |
3.1. Drivers |
3.2. Restraints |
3.3. Opportunities/Unmet Needs of the Market |
3.4. Trends |
3.5. Product Landscape |
3.6. New Product Launches |
3.7. Impact of COVID-19 on Market |
4. Global Depot Medroxyprogesterone Injection Market Analysis, 2019 - 2023 and Forecast 2024 - 2030 |
4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
4.3. Market Opportunity Analysis |
5. Global Depot Medroxyprogesterone Injection Market By Type , 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
5.1. Prescriptions |
5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.3. Market Opportunity Analysis |
5.2. Generic Prescriptions |
5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.2.3. Market Opportunity Analysis |
6. Global Depot Medroxyprogesterone Injection Market By Application, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
6.1. Contraceptive |
6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.1.3. Market Opportunity Analysis |
6.2. Hormone Replacement Therapy |
6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.2.3. Market Opportunity Analysis |
6.3. Treatment of Endometriosis |
6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.3.3. Market Opportunity Analysis |
6.4. Other |
6.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.4.3. Market Opportunity Analysis |
7. Global Depot Medroxyprogesterone Injection Market By End Users, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
7.1. Hospital |
7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.1.3. Market Opportunity Analysis |
7.2. Pharmacy |
7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.2.3. Market Opportunity Analysis |
7.3. Others |
7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.3.3. Market Opportunity Analysis |
8. Global Depot Medroxyprogesterone Injection Market By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
8.1. North America |
8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.1.3. Market Opportunity Analysis |
8.2. Europe |
8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.2.3. Market Opportunity Analysis |
8.3. Asia Pacific (APAC) |
8.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.3.3. Market Opportunity Analysis |
8.4. Middle East and Africa (MEA) |
8.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.4.3. Market Opportunity Analysis |
8.5. Latin America |
8.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.5.3. Market Opportunity Analysis |
9. North America Depot Medroxyprogesterone Injection Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
9.1. Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.1.1.Prescriptions |
9.1.2.Generic Prescriptions |
9.2. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.2.1.Contraceptive |
9.2.2.Hormone Replacement Therapy |
9.2.3.Treatment of Endometriosis |
9.2.4.Other |
9.3. End Users Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.3.1.Hospital |
9.3.2.Pharmacy |
9.3.3.Others |
9.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.4.1.United States of America (USA) |
9.4.2.Canada |
10. Europe Depot Medroxyprogesterone Injection Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
10.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.1.1.Prescriptions |
10.1.2.Generic Prescriptions |
10.2. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.2.1.Contraceptive |
10.2.2.Hormone Replacement Therapy |
10.2.3.Treatment of Endometriosis |
10.2.4.Other |
10.3. End Users Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.3.1.Hospital |
10.3.2.Pharmacy |
10.3.3.Others |
10.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.4.1.Germany |
10.4.2.France |
10.4.3.Italy |
10.4.4.United Kingdom (UK) |
10.4.5.Spain |
10.4.6.Rest of EU |
11. Asia Pacific (APAC) Depot Medroxyprogesterone Injection Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
11.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.1.1.Prescriptions |
11.1.2.Generic Prescriptions |
11.2. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.2.1.Contraceptive |
11.2.2.Hormone Replacement Therapy |
11.2.3.Treatment of Endometriosis |
11.2.4.Other |
11.3. End Users Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.3.1.Hospital |
11.3.2.Pharmacy |
11.3.3.Others |
11.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.4.1.China |
11.4.2.India |
11.4.3.Australia and New Zealand (ANZ) |
11.4.4.Japan |
11.4.5.Rest of APAC |
12. Middle East and Africa (MEA) Depot Medroxyprogesterone Injection Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
12.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.1.1.Prescriptions |
12.1.2.Generic Prescriptions |
12.2. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.2.1.Contraceptive |
12.2.2.Hormone Replacement Therapy |
12.2.3.Treatment of Endometriosis |
12.2.4.Other |
12.3. End Users Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.3.1.Hospital |
12.3.2.Pharmacy |
12.3.3.Others |
12.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.4.1.GCC Countries |
12.4.2.South Africa |
12.4.3.Rest of MEA |
13. Latin America Depot Medroxyprogesterone Injection Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
13.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.1.1.Prescriptions |
13.1.2.Generic Prescriptions |
13.2. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.2.1.Contraceptive |
13.2.2.Hormone Replacement Therapy |
13.2.3.Treatment of Endometriosis |
13.2.4.Other |
13.3. End Users Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.3.1.Hospital |
13.3.2.Pharmacy |
13.3.3.Others |
13.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.4.1.Brazil |
13.4.2.Mexico |
13.4.3.Rest of LA |
14. Competition Landscape |
14.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
14.2.1.Pfizer Inc. |
14.2.2.Fangtong Pharma. Co. Ltd |
14.2.3.Gador S.A. |
14.2.4.Sigma-Aldrich Co. LLC. |
14.2.5.Teva Pharmaceutical Industries Ltd. |
14.2.6.Greenstone LLC |
14.2.7.Serum Internation Ltd. |
14.2.8.West-Coast Pharmaceutical |
14.2.9.Arrow Pharma Group, |
14.2.10.Zuche Pharmaceuticals Pvt. Ltd. |
15. Research Methodology |
16. Appendix and Abbreviations |
Key Market Players